Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries

Christina Schut, Florence J Dalgard, Anthony Bewley, Andrea W M Evers, Uwe Gieler, Lars Lien, Francesca Sampogna, Sonja Ständer, Lucía Tomás-Aragonés, Nienke Vulink, Andrew Y Finlay, Franz J Legat, Geraldine Titeca, Gregor B Jemec, Laurent Misery, Csanád Szabó, Vesna Grivcheva-Panovska, Saskia Spillekom-van Koulil, Flora Balieva, Jacek C Szepietowski, Adam Reich, Bárbara Roque Ferreira, Andrey Lvov, Dmitry Romanov, Servando E Marron, Tamara Gracia-Cazaña, Ake Svensson, Ilknur K Altunay, Andrew R Thompson, Claudia Zeidler, Joerg Kupfer, ESDAP Study collaborators, Christina Schut, Florence J Dalgard, Anthony Bewley, Andrea W M Evers, Uwe Gieler, Lars Lien, Francesca Sampogna, Sonja Ständer, Lucía Tomás-Aragonés, Nienke Vulink, Andrew Y Finlay, Franz J Legat, Geraldine Titeca, Gregor B Jemec, Laurent Misery, Csanád Szabó, Vesna Grivcheva-Panovska, Saskia Spillekom-van Koulil, Flora Balieva, Jacek C Szepietowski, Adam Reich, Bárbara Roque Ferreira, Andrey Lvov, Dmitry Romanov, Servando E Marron, Tamara Gracia-Cazaña, Ake Svensson, Ilknur K Altunay, Andrew R Thompson, Claudia Zeidler, Joerg Kupfer, ESDAP Study collaborators

Abstract

Background: Body dysmorphic disorder (BDD) is a common psychiatric disorder associated with high costs for healthcare systems as patients may repeatedly ask for different, often not effective, interventions. BDD symptoms are more prevalent in patients with dermatological conditions than in the general population, but there are no large sample studies comparing the prevalence of BDD symptoms between patients with dermatological conditions and healthy skin controls.

Objectives: To compare the prevalence of BDD symptoms between patients with different dermatological conditions and healthy skin controls and to describe sociodemographic, physical and psychological factors associated with BDD symptoms to identify patients who may have a particularly high chance of having this condition.

Methods: This observational, cross-sectional, comparative multicentre study included 8295 participants: 5487 consecutive patients with different skin diseases (56% female) recruited among dermatological outpatients at 22 clinics in 17 European countries, and 2808 healthy skin controls (66% female). BDD symptoms were assessed by the Dysmorphic Concern Questionnaire. Sociodemographic data and information on psychological factors and physical conditions were collected. Each patient was given a dermatological diagnosis according to ICD-10 by a dermatologist. The study was registered with number DRKS00012745.

Results: The average participation rate of invited dermatological patients was 82.4% across all centres. BDD symptoms were five times more prevalent in patients with dermatological conditions than in healthy skin controls (10.5% vs. 2.1%). Patients with hyperhidrosis, alopecia and vitiligo had a more than 11-fold increased chance (adjusted Odds Ratio (OR) > 11) of having BDD symptoms compared with healthy skin controls, and patients with atopic dermatitis, psoriasis, acne, hidradenitis suppurativa, prurigo and bullous diseases had a more than sixfold increased chance (adjusted OR > 6) of having BDD symptoms. Using a logistic regression model, BDD symptoms were significantly related to lower age, female sex, higher psychological stress and feelings of stigmatization.

Conclusions: Clinical BDD symptoms are significantly associated with common dermatological diseases. As such symptoms are associated with higher levels of psychological distress and multiple unhelpful consultations, general practitioners and dermatologists should consider BDD and refer patients when identified to an appropriate service for BDD screening and management.

© 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

References

    1. Swann G. The skin is the body’s largest organ. J Vis Commun Med 2010; 33:148-9.
    1. Magin P, Adams J, Heading G, Pond D. ‘Perfect skin’, the media and patients with skin disease: a qualitative study of patients with acne, psoriasis and atopic eczema. Aust J Prim Health 2011; 17:181-5.
    1. Thompson AR, Kent G, Smith JA. Living with vitiligo: dealing with difference. Br J Health Psychol 2002; 7:213-25.
    1. Johnston S, Krasuska A, Millings A et al. Experiences of rosacea and its treatment: an interpretative phenomenological analysis. Br J Dermatol 2018; 178:154-60.
    1. Jankowiak B, Kowalewska B, Krajewska-Kułak E, Khvorik DF. Stigmatization and quality of life in patients with psoriasis. Dermatol Ther 2020; 10:285-96.
    1. Tomas-Aragones L, Marron SE. Body image and body dysmorphic concerns. Acta Derm Venereol 2016; 96:47-50
    1. Gieler T, Schmutzer G, Braehler E, Schut C et al. Shadows of beauty - prevalence of body dysmorphic concerns in Germany is increasing: data from two representative samples from 2002-2013. Acta Derm Venereol 2016; 96:83-90.
    1. Lahousen T, Linder D, Gieler T, Gieler U. [Body dysmorphic disorder: diagnostics and treatment in cosmetic dermatology]. Hautarzt 2017; 68:973-9 (in German).
    1. World Health Organization. ICD-11 for Mortality and Morbidity Statistics. Available at: (last accessed 1 March 2022).
    1. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Publishing, 2013.
    1. Veale D, Gledhill LJ, Christodoulou P, Hodsoll J. Body dysmorphic disorder in different settings: a systematic review and estimated weighted prevalence. Body Image 2016; 18:168-86.
    1. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 2005; 46:317-25.
    1. Phillips KA, Menard W, Fay C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatry 2006; 47:77-87.
    1. Rief W, Buhlmann U, Wilhelm S et al. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006; 36:877-85.
    1. Taqui AM, Shaikh M, Gowani SA et al. Body dysmorphic disorder: gender differences and prevalence in a Pakistani medical student population. BMC Psychiatry 2008; 8:20.
    1. Schieber K, Kolle I, de Zwaan M, Martin, A. Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria? J Psychosom Res 2015; 78:223-7.
    1. Möllmann A, Dietel FA, Hunger A, Buhlmann U. Prevalence of body dysmorphic disorder and associated features in German adolescents: a self-report survey. Psychiatry Res 2017; 254:263-7.
    1. Alomari AA, Makhdoom YM. Magnitude and determinants of body dysmorphic disorder among female students in Saudi public secondary schools. J Taibah Univ Med Sci 2019; 14:439-47.
    1. Perugi G, Giannotti D, Frare F et al. Prevalence, phenomenology and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population. Int J Psychiatry Clin Practice 1997; 1:77-82.
    1. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry 2006; 163:1280-2.
    1. Buhlmann U, Glaesmer H, Mewes R et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res 2010; 178:171-5.
    1. Chee I-S, Kim H-J, Lee Y, Kim JW. Body dysmorphic disorder, psychiatric symptoms, and quality of life in female dermatological patients. Neuropsychiatr Dis Treat 2020; 16:2921-8.
    1. Phillips KA, Grant J, Siniscalchi J, Albertini RS. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics 2001; 42:504-10.
    1. Herbst I, Jemec GBE. Body dysmorphic disorder in dermatology: a systematic review. Psychiatr Q 2020; 91:1003-10.
    1. Dalgard FJ, Gieler U, Tomas-Aragones L et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135:984-91.
    1. Magin P, Adams J, Heading G et al. Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Physician. 2006; 52:978-9.
    1. Magin PJ, Pond CD, Smith WT et al. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol 2008; 22:1435-44.
    1. Lahousen T, Kupfer J, Gieler U et al. Differences between psoriasis patients and skin-healthy controls concerning appraisal of touching, shame and disgust. Acta Derm Venereol 2016; 96:78-82.
    1. Hrehorów E, Salomon J, Matusiak L et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol 2012; 92:67-72.
    1. Kacar SD, Soyucok E, Bagcioglu E et al. The perceived stigma in patients with alopecia and mental disorder: a comparative study. Int J Trichol 2016; 8:135-40.
    1. van Beugen S, van Middendorp H, Ferwerda M et al. Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol 2017; 176:687-94.
    1. Sereflican B, Tuman TC, Tuman BA, Parlak AH. Type D personality, anxiety sensitivity, social anxiety, and disability in patients with acne: a cross-sectional controlled study. Postepy Dermatol Alergol 2019; 36:51-7.
    1. Marshall C, Bewley A. Social anxiety disorder and agoraphobia in dermatology patients; two cases and a review of the literature. Acta Derm Venereol 2015; 95:862-3.
    1. Phillips KA, Dufresne RG Jr, Wilkel C, Vittorio C. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000; 42:436-41.
    1. Uzun O, Basoglu C, Akar A et al. Body dysmorphic disorder in patients with acne. Compr Psychiatry 2003; 44:415-19.
    1. Vulink NC, Sigurdsson V, Kon M et al. [Body dysmorphic disorder in 3-8% of patients in outpatient dermatology and plastic surgery clinics]. Ned Tijdschr Genneskd 2006; 150:97-100 (in Dutch).
    1. Bowe WP, Leyden JJ, Crerand CE et al.. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol 2007; 57:222-30.
    1. Kaymak Y, Taner E, Simşek I. Body dysmorphic disorder in university students with skin diseases compared with healthy controls. Acta Derm Venereol 2009; 89:281-4.
    1. Conrado LA, Hounie AG, Diniz JB et al. Body dysmorphic disorder among dermatologic patients: prevalence and clinical features. J Am Acad Dermatol 2010; 63:235-43.
    1. Kacar SD, Ozuguz P, Bagcioglu E et al. The frequency of body dysmorphic disorder in dermatology and cosmetic dermatology clinics: a study from Turkey. Clin Exp Dermatol 2014; 39:433-8.
    1. Kacar SC, Ozuguz P, Bagcioglu E et al. Frequency of body dysmorphic disorder among patients with complaints of hair loss. Int J Dermatol 2016; 55:425-9.
    1. Thanveer F, Khunger N. Screening for body dysmorphic disorder in a dermatology outpatient setting at a tertiary care centre. J Cutan Aesthet Surg 2016; 9:188-91.
    1. Akinboro AO, Adelufosi AO, Onayemi O, Asaolu SO. Body dysmorphic disorder in patients attending a dermatology clinic in Nigeria: sociodemographic and clinical correlates. An Bras Dermatol 2019; 94:422-8.
    1. Marron SE, Miranda-Sivelo A, Tomas-Aragones L et al. Body dysmorphic disorder in patients with acne: a multicentre study. J Eur Acad Dermatol Venereol 2020; 34:370-6.
    1. Castle DJ, Phillips KA, Dufresne RG. Body dysmorphic disorder and cosmetic dermatology: more than skin deep. J Cosmet Dermatol 2004; 3:99-103.
    1. Ribeiro RVE. Prevalence of body dysmorphic disorder in plastic surgery and dermatology patients: a systematic review with meta-analysis. Aesth Plast Surg 2017; 41:964-70.
    1. Schmidt J, Martin A. Appearance teasing and mental health: gender differences and mediation effects of appearance-based rejection sensitivity and dysmorphic concerns. Front Psychol 2019; 10:579.
    1. Enander J, Ivanov VZ, Mataix-Cols D et al. Prevalence and heritability of body dysmorphic symptoms in adolescents and young adults: a population-based nationwide twin study. Psychol Med 2018; 48:2740-7.
    1. Dalgard FJ, Bewley A, Evers AW et al. Stigmatisation and body image impairment in dermatological patients: protocol for an observational multicentre study in 16 European countries. BMJ Open 2018; 8:e024877.
    1. Oosthuizen P, Lambert T, Castle DJ. Dysmorphic concern: prevalence and associations with clinical variables. Aust N Z J Psychiatry 1998; 32:129-32.
    1. Jorgensen L, Castle D, Roberts C, Groth-Marnat G. A clinical validation of the dysmorphic concern questionnaire. Aust N Z J Psychiatry 2001; 35:124-8.
    1. Stangier U, Janich C, Adam-Schwebe S et al. Screening for body dysmorphic disorder in dermatological outpatients. Dermatol Psychosom 2003; 4:66-71.
    1. Mancuso SG, Knoesen NP, Castle DJ. The Dysmorphic Concern Questionnaire: a screening measure for body dysmorphic disorder. Aust N Z J Psychiatry 2010; 44:535-42.
    1. Schieber K, Kollei I, de Zwaan M, Martin A. The Dysmorphic Concern Questionnaire in the German general population: psychometric properties and normative data. Aesth Plast Surgery 2018; 42:1412-20.
    1. Kroenke K, Spitzer RL, Williams JB, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010; 32:345-59.
    1. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17:13-35.
    1. Lawrence JW, Fauerbach JA, Heinberg LJ et al. The reliability and validity of the Perceived Stigmatization Questionnaire (PSQ) and the Social Comfort Questionnaire (SCQ) among an adult burn survivor sample. Psychol Assess 2006; 18:106-11.
    1. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24:385-96.
    1. Faravelli C, Salvatori S, Galassim F et al. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol 1997; 32:24-9.
    1. Brohede S, Wingren G, Wijma B, Wijma K. Prevalence of body dysmorphic disorder among Swedish women: a population-based study. Compr Psychiatry 2015; 58:108-15.
    1. Koran L, Abujaoude E, Large M, Serpe R. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr 2008; 13:316-22.
    1. Drill R, Nakash O, DeFife JA, Westen D. Assessment of clinical information: comparison of the validity of a Structured Clinical Interview (the SCID) and the Clinical Diagnostic Interview. J Nerv Ment Dis 2015; 203:459-62.
    1. First MB, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for DSM-5 disorders, clinician version (SCID-5-CV). Washington, DC: American Psychiatric Publishing, 2015.
    1. Stangier U, Müller T, Adam-Schwebe S, Wolter M. Discrimination of facial stimuli in body dysmorphic disorder. J Abnorm Psychol 2008; 117:435-43.
    1. van Beugen S, Maas J, van Laarhoven AIM et al. Implicit stigmatization-related biases in individuals and their significant others. Health Psychol 2016; 35:861-5.
    1. Thompson AR, Clarke SA, Newell R, Gawkrodger G. Vitiligo linked to stigmatisation in British South Asian women: a qualitative study of the experiences of living with vitiligo. Br J Dermatol 2010; 163:481-6.
    1. Wilson JB, Arpey CJ. Body dysmorphic disorder: suggestions for detection and treatment in a surgical dermatology practice. Dermatol Surg 2004; 30:1391-9.
    1. Szepietowski JC, Salomon J, Pacan P et al. Body dysmorphic disorder and dermatologists. J Eur Acad Dermatol Venereol 2009; 22:795-9.
    1. Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001; 62:517-22.
    1. Ablett K, Thompson AR. Parental, child and adolescent experience of chronic skin conditions: a meta-ethnography and review of the qualitative literature. Body Image 2016; 19:175-85.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit